絞り込み

16641

広告

Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study.

著者 Napolitano M , Saccullo G , Malato A , Sprini D , Ageno W , Imberti D , Mascheroni D , Bucherini E , Gallucci P , D'Alessio A , Prantera T , Spadaro P , Rotondo S , Di Micco P , Oriana V , Urbano O , Recchia F , Ghirarduzzi A , Lo Coco L , Mancuso S , Cas
J Clin Oncol.2014 Sep 29 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (100view , 0users)

Full Text Sources

Medical

Other Literature Sources

We evaluated the role of residual vein thrombosis (RVT) to assess the optimal duration of anticoagulants in patients with cancer who have deep vein thrombosis (DVT) of the lower limbs.
PMID: 25267738 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード